DEF 14C

DEF 14C Filing

Company: ENDONOVO THERAPEUTICS, INC.
Filed: August 28, 2018
Period of Report: August 28, 2018
Accession Number: 0001493152-18-012644

View Document ↗ View on SEC.gov ↗